Genmab Announces Epcoritamab Investigational Combination Therapy Demonstrates High Response Rates in Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) Eligible for Autologous Stem Cell Transplantation (ASCT)
Media ReleaseCOPENHAGEN, Denmark; June 15, 2025 Results from the EPCORE® NHL-2 trial…
MEXC IgniteX Partners with Superteam to Launch Revolutionary “IgniteX Solana Talent Lab” at Solana Summit APAC
VICTORIA, Seychelles, June 5, 2025 /PRNewswire/ --Â MEXC IgniteX, the $30 million global…
